Authors : Blanchard CE; School of Systems Biology, George Mason University, 10920 George Mason Circle, Room 2016, Manassas, VA, 20110, USA.; Gomeiz AT

Subjects: Drug Resistance, Neoplasm*/Drug Resistance, Neoplasm*/Drug Resistance, Neoplasm*/drug effects ; Signal Transduction*/Signal Transduction*/Signal Transduction*/drug effects ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology

Source: Cell communication and signaling : CCS [Cell Commun Signal] 2024 Jul 26; Vol. 22 (1), pp. 377. Date of Electronic Publication: 2024 Jul 26.Publisher: BioMed Central Country of Publication: England NLM ID: 101170464 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-811X

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Recent Advances on Pt-Based Compounds for Theranostic Applications.

Authors : Ferrari G; Department of Chemistry, Maynooth University, W23 F2H6 Maynooth, Ireland.; Lopez-Martinez I

Subjects: Theranostic Nanomedicine* ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology

Source: Molecules (Basel, Switzerland) [Molecules] 2024 Jul 23; Vol. 29 (15). Date of Electronic Publication: 2024 Jul 23.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Synthesis, characterization and biological applications of substituted indolo[2,1-b]quinazolin-12(6H)-one based rhenium(I) organometallic compounds.

Authors : Padariya A; Department of Chemistry, Sardar Patel University, Vallabh Vidyanagar. .; Nirbhay K Savaliya

Subjects: Rhenium*/Rhenium*/Rhenium*/chemistry ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/chemical synthesis

Source: Acta chimica Slovenica [Acta Chim Slov] 2024 Jun 10; Vol. 71 (2), pp. 334-352. Date of Electronic Publication: 2024 Jun 10.Publisher: Slovenian Chemical Society Country of Publication: Slovenia NLM ID: 101247110 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Base-Catalyzed Reaction of Isatins and (3-Hydroxyprop-1-yn-1-yl)phosphonates as a Tool for the Synthesis of Spiro-1,3-dioxolane Oxindoles with Anticancer and Anti-Platelet Properties.

Authors : Murashkina AV; Department of Chemistry, M. V. Lomonosov Moscow State University, 119991 Moscow, Russia.; Bogdanov AV

Subjects: Oxindoles*/Oxindoles*/Oxindoles*/chemistry ; Oxindoles*/Oxindoles*/Oxindoles*/pharmacology ; Oxindoles*/Oxindoles*/Oxindoles*/chemical synthesis

Source: Molecules (Basel, Switzerland) [Molecules] 2024 Oct 08; Vol. 29 (19). Date of Electronic Publication: 2024 Oct 08.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Computational screening and molecular docking of compounds from Traditional Chinese Medicine (TCM) by targeting DNA topoisomerase I to design potential anticancer drugs.

Authors : Shimu MSS; Genetic Engineering and Biotechnology, University of Rajshahi, Rajshahi, Bangladesh.

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/chemistry ; DNA Topoisomerases, Type I*/DNA Topoisomerases, Type I*/DNA Topoisomerases, Type I*/metabolism

Source: PloS one [PLoS One] 2024 Sep 12; Vol. 19 (9), pp. e0310364. Date of Electronic Publication: 2024 Sep 12 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Exploring pta Alternatives in the Development of Ruthenium-Arene Anticancer Compounds.

Authors : Kljun J; Faculty of Chemistry and Chemical Technology, University of Ljubljana, Večna pot 113, SI-1000 Ljubljana, Slovenia.; Rebernik M

Subjects: Ruthenium*/Ruthenium*/Ruthenium*/pharmacology ; Ruthenium*/Ruthenium*/Ruthenium*/chemistry ; Phosphines*

Source: Molecules (Basel, Switzerland) [Molecules] 2023 Mar 09; Vol. 28 (6). Date of Electronic Publication: 2023 Mar 09.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Synthesis of a New Class of β -Carbonyl Selenides Functionalized with Ester Groups with Antioxidant and Anticancer Properties-Part II.

Authors : Laskowska A; Department of Organic Chemistry, Faculty of Chemistry, Nicolaus Copernicus University, 7 Gagarin Street, 87-100 Torun, Poland.; Pacuła-Miszewska AJ

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/chemistry ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/chemical synthesis

Source: Molecules (Basel, Switzerland) [Molecules] 2024 Jun 16; Vol. 29 (12). Date of Electronic Publication: 2024 Jun 16.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Prospects of marine-derived compounds as potential therapeutic agents for glioma.

Authors : Liu Y; Department of Pathology, Xiangya Changde Hospital, Changde, China.; Zhou Z

Subjects: Glioma*/Glioma*/Glioma*/drug therapy ; Glioma*/Glioma*/Glioma*/pathology ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/drug therapy

Source: Pharmaceutical biology [Pharm Biol] 2024 Dec; Vol. 62 (1), pp. 513-526. Date of Electronic Publication: 2024 Jun 12.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9812552 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Complete response in a lung adenocarcinoma with pleural metastases initially treated with gefitinib and switched to osimertinib after cerebral oligo-progression with unknown T790M mutation: a case report and review of literature.

Authors : Hachlaf M; Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco. .; Lkhoyaali S

Subjects: Aniline Compounds*/Aniline Compounds*/Aniline Compounds*/therapeutic use ; Acrylamides*/Acrylamides*/Acrylamides*/therapeutic use ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/drug therapy

Source: Journal of medical case reports [J Med Case Rep] 2024 Aug 08; Vol. 18 (1), pp. 374. Date of Electronic Publication: 2024 Aug 08.Publisher: BioMed Central Country of Publication: England NLM ID: 101293382 Publication Model: Electronic Cited Medium: Internet ISSN: 1752-1947

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Quantitative systems pharmacology modeling of tumor heterogeneity in response to BH3-mimetics using virtual tumors calibrated with cell viability assays.

Authors : Derippe T; Institut de Recherches Internationales Servier, Suresnes, France.; Inserm, UMRS-1144, Optimisation Thérapeutique en Neuropsychopharmacologie, Université Paris Cité, Paris, France.

Subjects: Cell Survival*/Cell Survival*/Cell Survival*/drug effects ; Apoptosis*/Apoptosis*/Apoptosis*/drug effects ; Bridged Bicyclo Compounds, Heterocyclic*/Bridged Bicyclo Compounds, Heterocyclic*/Bridged Bicyclo Compounds, Heterocyclic*/pharmacology

Source: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2024 Jul; Vol. 13 (7), pp. 1252-1263. Date of Electronic Publication: 2024 May 15.Publisher: Wiley Country of Publication: United States NLM ID: 101580011 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Signaling dynamics in coexisting monoclonal cell subpopulations unveil mechanisms of resistance to anti-cancer compounds.

Recent Advances on Pt-Based Compounds for Theranostic Applications.

Synthesis, characterization and biological applications of substituted indolo[2,1-b]quinazolin-12(6H)-one based rhenium(I) organometallic compounds.

Base-Catalyzed Reaction of Isatins and (3-Hydroxyprop-1-yn-1-yl)phosphonates as a Tool for the Synthesis of Spiro-1,3-dioxolane Oxindoles with Anticancer and Anti-Platelet Properties.

Computational screening and molecular docking of compounds from Traditional Chinese Medicine (TCM) by targeting DNA topoisomerase I to design potential anticancer drugs.

Exploring pta Alternatives in the Development of Ruthenium-Arene Anticancer Compounds.

Synthesis of a New Class of β -Carbonyl Selenides Functionalized with Ester Groups with Antioxidant and Anticancer Properties-Part II.

Prospects of marine-derived compounds as potential therapeutic agents for glioma.

Complete response in a lung adenocarcinoma with pleural metastases initially treated with gefitinib and switched to osimertinib after cerebral oligo-progression with unknown T790M mutation: a case report and review of literature.

Quantitative systems pharmacology modeling of tumor heterogeneity in response to BH3-mimetics using virtual tumors calibrated with cell viability assays.

اتصل بنا

اتبع